Related by context. All words. (Click for frequent words.) 75 GvHD 72 haematologic 71 Toxicities 71 relapsed MM 71 chronic GVHD 71 hematologic toxicity 71 mycophenolate mofetil MMF 71 Fludarabine 71 metastatic malignant 71 hypereosinophilic syndrome 70 TNF antagonist 70 leukemia AML 70 superficial bladder cancer 70 potentially hepatotoxic 70 TMP SMX 69 cervical intraepithelial neoplasia 69 dysplastic lesions 69 basiliximab 69 Xanafide 69 corticosteroid therapy 69 dasatinib Sprycel ® 69 immunocompetent patients 69 severe hypersensitivity reactions 69 histologic subtype 69 ara C 69 Vidaza azacitidine 69 cytomegalovirus infection 69 peritumoral brain edema 69 gastrointestinal stromal tumors GIST 69 hepatorenal syndrome 69 grade cervical intraepithelial 69 CMV reactivation 69 leucopenia 69 Severe Primary IGFD 69 vesicoureteral reflux 69 invasive aspergillosis 69 refractory NSCLC 69 alkylating agent 69 FASLODEX 69 Mitomycin C 69 metastatic malignant melanoma 68 mycophenolate mofetil 68 Pharmacokinetics PK 68 acute leukemias 68 CMV infection 68 non metastatic osteosarcoma 68 Candida infection 68 myelodysplastic myeloproliferative diseases 68 situ CIS 68 peripheral sensory neuropathy 68 allograft rejection 68 fallopian tube cancers 68 severe neutropenia 68 nonalcoholic steatohepatitis NASH 68 erythropoietic 68 mycophenolate 68 visilizumab 68 anthracycline chemotherapy 68 CYT# potent vascular disrupting 68 transplantation HCT 68 acute GVHD 68 cisplatin chemotherapy 68 taxane chemotherapy 68 Hypotension 68 metastatic GIST 68 hemorrhagic cystitis 68 graft dysfunction 68 epithelial tumors 68 hematologic disorders 68 systemic corticosteroids 67 nephrotoxicity 67 severe oral mucositis 67 Ribavirin causes 67 herpes zoster shingles 67 antithymocyte globulin 67 dexamethasone Decadron 67 steroid refractory 67 erlotinib Tarceva ® 67 mixed hyperlipidemia 67 osteosarcomas 67 ß blockers 67 Follicular Lymphoma 67 ribavirin therapy 67 gastrointestinal stromal tumor 67 immunomodulatory therapy 67 pheochromocytoma 67 polycythemia vera essential thrombocythemia 67 invasive candidiasis 67 basal cell carcinoma BCC 67 leukemia ALL 67 purpura ITP 67 Host Disease GvHD 67 torsade de pointes 67 chronic eosinophilic leukemia 67 cell lymphoma CTCL 67 BCG refractory 67 tumor lysis syndrome 67 colorectal adenoma 67 urothelial carcinoma 67 atypical hemolytic uremic syndrome 67 azacytidine 67 systemic fungal infections 67 Sezary syndrome 67 intra articular injection 67 parasitemia 67 anthracycline taxane 67 hematologic abnormalities 67 deep venous thromboses 67 antimetabolite 67 corticosteroid dose 67 candidemia 67 metastatic neuroendocrine tumors 67 either acutely decompensated 67 delayed CINV 67 posterior uveitis 67 hypomagnesemia 67 Nilotinib 67 adrenal suppression 67 hyperphenylalaninemia HPA due 67 SPRYCEL ® 67 hypercalcemia 67 calcineurin inhibitor 67 papillary renal cell carcinoma 67 neutropenia dehydration dyspnea 67 biologic DMARD 67 idiopathic thrombocytopenic purpura ITP 67 tumors GIST 67 CIMZIA TM 67 cervical carcinoma 67 ® lenalidomide 67 histological subtype 67 adriamycin 67 hematological toxicity 67 cisplatin gemcitabine 67 AGILECT R 66 Irinotecan 66 neutropaenia 66 ADPKD 66 thalidomide Thalomid 66 biochemical relapse 66 GISTs 66 Telintra 66 anthracycline therapy 66 receptor tyrosine kinase inhibitor 66 fallopian tube carcinoma 66 relapsed Acute Myeloid 66 CIMZIA TM certolizumab pegol 66 immunosuppressive agents 66 docetaxel Taxotere ® 66 imatinib therapy 66 Gleevec resistant 66 nucleotide analog 66 eosinophilic asthma 66 pharyngitis tonsillitis 66 VAPRISOL 66 precancerous cervical lesions 66 Bezielle 66 trastuzumab Herceptin ® 66 Natalizumab 66 anthracyclines taxanes 66 colorectal liver metastases 66 mRCC 66 anagrelide 66 induce remission 66 conventional DMARDs 66 follicular lymphoma FL 66 nitrofurantoin 66 Thrombocytopenia 66 Omacetaxine 66 refractory chronic lymphocytic 66 HBeAg negative 66 vWD 66 bacterial prostatitis 66 de novo kidney transplant 66 HeFH 66 Decitabine 66 polycythemia vera PV 66 cetuximab Erbitux ® 66 secondary hyperparathyroidism 66 PNP inhibitor 66 MAGE A3 ASCI 66 immunosuppressives 66 metastatic bladder 66 idiopathic thrombocytopenic purpura 66 Fludara ® 66 urothelial bladder cancer 66 refractory gout 66 demonstrated antitumor activity 66 orchitis 66 interferon ribavirin 66 Kinoid 66 intravesical therapy 66 Amgen Neulasta R 66 lenalidomide Revlimid R 66 cytopenias 66 pancreatic insufficiency 66 skeletal metastases 66 diabetic gastroparesis 66 heparin induced thrombocytopenia 66 cutaneous T 66 HBeAg positive patients 66 Dasatinib 66 Acute Myeloid Leukaemia AML 66 FXIII 66 gastrointestinal toxicity 66 relapsing multiple sclerosis 66 renal toxicity 66 recurrent glioblastoma multiforme 66 Doxil ® 66 proctitis 66 alefacept 66 Leukemias 66 saline placebo 66 radiotherapy RT 66 CTAP# Capsules 66 unfavorable cytogenetics 66 recurrent genital herpes 66 grade cervical dysplasia 66 thromboembolic events 65 alpha interferons 65 neutropenic 65 cervical lesions 65 disease GVHD 65 bullous 65 biliary tract cancer 65 NPM1 mutation 65 FUSILEV enhances 65 MULTAQ 65 CINTREDEKIN BESUDOTOX 65 leukemia APL 65 dasatinib Sprycel 65 Orally administered 65 INFERGEN 65 immunosuppressed patients 65 trans retinoic acid ATRA 65 candidiasis 65 idarubicin 65 BCR ABL mutations 65 post herpetic neuralgia PHN 65 protease inhibitors PIs 65 adrenal insufficiency 65 chronic idiopathic thrombocytopenic purpura 65 pulmonary hypertension PH 65 essential thrombocythemia ET 65 complement inhibitor eculizumab 65 thrombotic complications 65 Pemetrexed 65 radioiodine therapy 65 busulfan 65 Squamous 65 myelodysplastic syndrome MDS 65 relapsed ovarian cancer 65 imatinib Gleevec ® 65 hypercholesterolaemia 65 TELINTRA 65 octreotide 65 corticosteroid dexamethasone 65 refractory indolent non 65 synthetic retinoid 65 xanthine oxidase inhibitor 65 Hurler syndrome 65 rFVIIa 65 fluocinolone acetonide 65 VUR 65 smoldering multiple myeloma 65 Acute myeloid leukemia 65 lymphocytic leukemia 65 TNF Tumor Necrosis Factor 65 Paraplatin ® 65 vaginal candidiasis 65 gastric adenocarcinoma 65 PAOD 65 Myelofibrosis 65 hyperammonemia 65 metastatic CRC 65 transaminase elevations 65 MCyR 65 refractory cutaneous T 65 cidofovir 65 HCV Genotype 65 Cutaneous T 65 acetonide FA 65 myelofibrosis polycythemia vera 65 immune thrombocytopenic purpura ITP 65 anthracycline containing 65 ribavirin RBV 65 Major Depressive Disorder MDD 65 allogeneic hematopoietic stem cell 65 alfa 2a 65 endometrial hyperplasia 65 cystic fibrosis chronic pancreatitis 65 ALT flares 65 parathyroid carcinoma 65 CLL SLL 65 choroidal neovascularization 65 potassium binder 65 hematopoietic cancers 65 tuberous sclerosis TS 65 Cyclosporine 65 riociguat 65 androgen deprivation 65 keloid scarring 65 ANCA associated 65 antiplatelet medications 65 CIMZIA ™ 65 amphotericin B 65 CMV disease 65 ertapenem 65 BCG refractory carcinoma 65 prednisone prednisolone 65 chronic immune thrombocytopenic 65 superficial basal cell carcinoma 65 overactive bladder syndrome 65 recurrent DVT 65 Hydroxyurea 65 lumiliximab 65 LHRH agonists 65 systemic corticosteroid 65 fibrinolytic 65 FOLFIRI alone 65 oral vancomycin 65 aspartate aminotransferase AST 65 valsartan amlodipine 65 myeloproliferative diseases 65 Carcinoid tumors 65 Ranibizumab 65 leukemia CLL 65 octreotide LAR 65 imatinib mesylate 65 Hurthle cell 65 Tasimelteon 65 idiopathic PAH 65 intravesical 65 administered subcutaneously 65 EGFRIs 65 NMDA antagonists 65 potassium sparing diuretics 65 vWF 65 sodium stibogluconate 65 orally administered inhibitor 65 mitomycin C 65 imatinib resistance 65 EXJADE 65 LHRH analogues 65 Xyfid TM 65 CYP #A# 65 fluconazole resistant 65 leiomyomas 65 ALK inhibitor 65 Actinic Keratosis 65 lupus nephritis 65 assessing T DM1 65 oral prodrug 65 allogeneic HSCT 65 GH deficiency 65 Anthracycline 65 amikacin 65 thromboembolic complications 65 Retreatment 65 anterior uveitis 65 lymphoproliferative disorder 65 cervical lymph nodes 65 palifermin 65 daunorubicin 65 hyperkalemia 64 SHPT 64 dual endothelin receptor antagonist 64 FluCAM arm 64 nucleoside analog 64 Capecitabine 64 nicardipine 64 CHOP chemotherapy 64 paclitaxel Taxol 64 post surgical adhesions 64 platelet inhibitor 64 mitoxantrone plus 64 clodronate 64 noninfectious uveitis 64 INVANZ 64 pimecrolimus 64 intratumoral 64 Bosentan 64 response CCyR 64 Vidofludimus 64 C1 INH deficiency 64 Cardiotoxicity 64 haematological toxicity 64 rhGH 64 ganciclovir 64 cytotoxic chemotherapy 64 hepatic cirrhosis 64 tigecycline 64 external genital lesions 64 Soft Tissue Sarcoma 64 Dapagliflozin 64 chronic renal disease 64 leukotriene receptor antagonist 64 Tacrolimus 64 COPD exacerbation 64 imatinib Gleevec 64 recurrent metastatic 64 denileukin diftitox 64 thromboembolic disease 64 deferiprone 64 bacteriuria 64 thrombocytopenia neutropenia 64 small molecule Hedgehog 64 alkylating agents 64 Bosutinib 64 dosing frequency 64 bevacizumab Avastin ® 64 hypocalcemia 64 allogeneic bone marrow 64 delayed onset CINV 64 metastatic pancreatic 64 unresectable tumors 64 debilitating complication 64 invasive fungal infections 64 HSCT 64 colorectal carcinoma 64 cutaneous squamous cell carcinoma 64 chemotherapy induced neutropenia 64 chlorambucil 64 severe gastroparesis 64 neutropenic patients 64 Pathway Inhibitor 64 Lymphocytic 64 carcinoids 64 5 Fluorouracil 64 tumor xenograft models 64 intrahepatic 64 systemic immunosuppressive drugs 64 drug zotarolimus 64 synthase TS 64 bolus dose 64 vinca alkaloid 64 subependymal giant cell 64 docetaxel chemotherapy 64 Catheter Associated 64 NAbs 64 relapsing remitting MS RRMS 64 flutamide 64 adrenocorticotropic hormone 64 HIV HCV coinfected 64 membranous nephropathy 64 relapsed AML 64 grade glioma 64 Methylnaltrexone 64 immunocompetent 64 amenorrhoea 64 SinuNase TM 64 Interferon Beta 64 hyperplasia BPH 64 systemic hypotension 64 precursor lesions 64 Chronic HCV 64 Non Alcoholic Steatohepatitis 64 pT3 64 Pegloticase 64 postoperative AF 64 hA# 64 Dacogen decitabine 64 4mg/kg 64 Glucocorticoid 64 β blockers 64 non hematological toxicities 64 Kamada AAT 64 liposomal formulation 64 Graft Versus Host 64 esophagitis 64 Liver transplantation 64 LHRH receptor positive 64 Degarelix 64 Lupus nephritis 64 hyperoxaluria 64 thyroid carcinoma 64 lymphoid tumors 64 SSc 64 Pegylated Interferon 64 Bronchiectasis 64 onset diabetes mellitus 64 MYCAMINE 64 DMARDS 64 Patients Receiving 64 Chronic Myelogenous Leukemia CML 64 ZOLINZA 64 hemorrhagic complications 64 immune suppressants 64 polyarticular 64 malignant ascites 64 Adjunctive 64 calcineurin inhibitors 64 rALLy 64 primary hyperparathyroidism 64 recurrent malignant glioma 64 TNF alpha antagonist 64 organ transplant rejection 64 Mitoxantrone 64 MYLOTARG 64 vidofludimus 64 somatostatin analogs 64 MGd 64 adalimumab Humira 64 blastic phase 64 steroid refractory ulcerative 64 hemodynamically significant 64 postsurgical pain 64 immune dysregulation 64 antimicrobial prophylaxis 64 novel VDA molecule 64 sodium glucose cotransporter 64 steroid refractory GvHD 64 Parnate 64 ovarian carcinoma 64 Traficet EN 64 Lubiprostone 64 familial amyloidotic polyneuropathy FAP 64 adverse cytogenetics 64 anemia neutropenia 64 pediatric Crohn disease 64 antiandrogen 64 prostate carcinoma 64 vapreotide acetate 64 BARACLUDE ® 64 Zollinger Ellison Syndrome 64 topical calcineurin inhibitors 64 aplastic anemia AA 64 receiving immunosuppressive therapy 64 neovascularisation 64 effector function 64 intravenous bisphosphonates 64 velafermin 64 pegylated interferon alfa 64 PREZISTA r 64 latent tuberculosis infection 64 dermatologic toxicities 64 precancerous condition 64 colorectal cancer liver metastases 64 juvenile idiopathic arthritis JIA 64 oral thrush 64 neutropenia thrombocytopenia 64 cytoreduction 64 Adjuvant chemotherapy 64 Nebulized 64 varices 64 recombinant erythropoietin 64 constipation OIC 64 variceal bleeding 64 unresectable HCC 64 acute humoral rejection 64 LHRH antagonists 64 Vfend 64 lactate dehydrogenase 64 Troxatyl 64 relapsed refractory 64 hemoglobinopathies 64 IRX 2 64 myelosuppression 64 MDS MPD 64 ORENCIA ® 64 diabetes mellitus DM 64 bone marrow suppression 64 steroid dexamethasone 64 Idiopathic Thrombocytopenic Purpura ITP 64 Diffuse Large B 64 pamidronate 64 PTLD 64 salmeterol fluticasone 64 Infusion Reactions Severe 64 gastrointestinal stromal tumor GIST 64 DOXIL 64 LYSTEDA 64 hepatocellular cancer 64 Pegasys ® 64 ATIR 64 lichen planus 64 recurrent glioma 64 Chronic Prostatitis 64 prostate adenocarcinoma 64 trimethoprim sulfamethoxazole 64 bacillus Calmette Guerin 64 pegylated interferon alpha 64 rhIGF-I/rhIGFBP-3 64 T2DM 64 lupus erythematosus 64 NMIBC 64 certolizumab 64 Hormone Refractory Prostate Cancer 64 chronic hemodialysis 64 NAGS deficiency 64 CMV seropositive 64 Barrett esophagus BE 64 plasmid encoding 63 hyperparathyroidism 63 papillary thyroid carcinoma 63 immune modulator 63 Navelbine ® 63 refractory chronic myeloid 63 Gleevec imatinib mesylate 63 CIN2 + 63 Hodgkin lymphoma HL 63 nucleoside analogs 63 premalignant lesion 63 lysosomal storage disease 63 nonmetastatic 63 prolonged QT interval 63 EGFR HER2 63 panitumumab Vectibix 63 R lenalidomide 63 intravascular hemolysis 63 nephrotoxic 63 cholangiocarcinoma 63 hormone LHRH antagonist 63 Hepatocellular Carcinoma HCC 63 MALT lymphoma 63 Stomatitis 63 fluoropyrimidine 63 deferoxamine 63 Glioblastoma Multiforme 63 esophageal candidiasis 63 imiquimod cream 63 Albuferon TM 63 mucosal inflammation 63 cobiprostone 63 replicon 63 hepatic enzymes 63 Vidaza ® 63 acromegalic patients 63 ADP receptor antagonist 63 DFMO 63 antiarrhythmic drugs 63 pancytopenia 63 Kepivance 63 elevated transaminases 63 relapsed leukemia 63 antimuscarinic 63 lomitapide 63 ALN TTR# 63 basal cell nevus syndrome 63 intratympanic 63 FOLFOX6 63 gemcitabine Gemzar ® 63 gemcitabine Gemzar 63 protease inhibitor PI 63 systemic toxicity 63 #mg/m# [001] 63 Tarceva TM 63 Bacillus Calmette Guerin BCG 63 Melphalan 63 chronic HCV 63 myopathy rhabdomyolysis 63 chlamydial 63 mycosis fungoides 63 Annamycin 63 radiochemotherapy 63 sitaxsentan 63 intraepithelial neoplasia 63 immunosuppressive medications 63 recurrent GBM 63 glucocorticoid therapy 63 ALN TTR 63 Diabetic Neuropathy 63 neuroendocrine cancers 63 malignant neoplasms 63 erythema nodosum 63 indolent NHL 63 efalizumab 63 pharmacokinetic interactions 63 epithelial ovarian 63 kidney urologic 63 chronic thromboembolic pulmonary 63 APTIVUS r 63 receiving prophylactic anticoagulation 63 node metastases 63 Zollinger Ellison syndrome 63 heavily pretreated 63 IMiDs 63 recurrent NSCLC 63 Zorbtive TM 63 metastatic gastric 63 sorafenib tablets 63 HER2 overexpression 63 cranial irradiation 63 Prostatic 63 fibrin deposition 63 Zoledronic acid 63 Raynaud syndrome 63 bleomycin 63 Central Retinal Vein 63 TMS Therapy 63 hematologic adverse 63 FVIIa 63 2 methoxyestradiol 63 von Willebrand Factor 63 cytostatic 63 transplantation HSCT 63 neovascular 63 cerebral vasospasm 63 juvenile idiopathic arthritis 63 voriconazole 63 chemoradiation therapy 63 systemically administered 63 myeloablative 63 DEFLUX 63 chronic myeloid 63 generalized seizures 63 mTOR inhibitors 63 danazol 63 antithyroid 63 Fluorouracil 63 leukoencephalopathy 63 histologically confirmed 63 estramustine 63 systemic anaplastic large 63 generation purine nucleoside 63 carcinoid syndrome 63 trans retinoic acid 63 colorectal adenocarcinoma 63 ritonavir boosted 63 Relapsed Refractory 63 hypophosphatemia 63 iron chelation 63 carcinoid tumors 63 pericardial effusion 63 cromolyn sodium 63 cytotoxic therapy 63 metformin monotherapy 63 severe malignant osteopetrosis 63 ICD shocks 63 inflammatory acne 63 Leukine ® 63 acute myeloid 63 ipratropium bromide 63 neutropenic fever 63 recurrent glioblastoma 63 CD3 monoclonal antibody 63 INVEGA ® 63 overt nephropathy 63 metastatic renal cell carcinoma 63 LEUKINE 63 lung fibrosis 63 Graft versus 63 Naive Patients 63 pyridostigmine 63 sarcomatoid 63 PSA nadir 63 atopic dermatitis AD 63 Abrupt discontinuation 63 thromboembolic 63 erythropoiesis 63 multiple myeloma MM 63 gastrointestinal perforation 63 hepatic metastases 63 TNF alpha inhibitor 63 methotrexate therapy 63 clotrimazole 63 posaconazole 63 β blocker 63 direct thrombin inhibitors 63 aprepitant 63 lymphoma CTCL 63 corticosteroids immunoglobulins 63 galiximab 63 mediastinitis 63 pegfilgrastim 63 Mg Usa 63 nonischemic 63 inotropic 63 CMV infections 63 hypervascular tumors 63 6 mercaptopurine 63 systemic lupus erythematosus SLE 63 chronic constipation CC 63 HbF 63 brand ciclesonide HFA 63 inhalation powder 63 arteriovenous fistula 63 non splenectomized 63 Gliadel Wafer 63 pathophysiological effects 63 neutrophil count 63 gastrointestinal toxicities 63 Myelodysplastic Syndrome MDS 63 hyperacute 63 HBeAg 63 efaproxiral 63 febrile neutropenia 63 Peg IFN 63 chimeric monoclonal antibody 63 small molecule tyrosine 63 Chronic Sinusitis 63 polymicrobial infections 63 Host Disease 63 CD8 + cytotoxic 63 serologically active systemic lupus 63 lymphoid blast 63 Carvedilol 63 nilotinib Tasigna ® 63 benign prostatic hypertrophy BPH 63 prostanoid 63 Alphanate R 63 hypersensitivity reaction 63 Simulect 63 PEG IFN 63 hormone refractory 63 OMNARIS HFA 63 Intravitreal 63 erythematosus 63 Chronic lymphocytic leukemia 63 cytopenia 63 Primary Hypercholesterolemia 63 suppressive therapy 63 Granulocyte Colony Stimulating Factor 63 Mg Uk 63 neoplasias 63 interleukin IL -# 63 Candida infections 63 mu opioid receptor antagonist 63 chronic periodontitis 63 Chemokine Receptor 63 methimazole 63 adrenocorticotropic hormone ACTH 63 granulomatous 63 oral JAK1 63 proliferative diabetic retinopathy 63 DEB# 63 diarrhea predominant irritable 63 KETEK 63 myeloproliferative neoplasms 63 gemcitabine cisplatin 63 elevated ALT 63 VEGF inhibitors 63 Ziprasidone 63 sJIA 63 endometrial carcinoma 63 pyrazinamide 63 cirrhosis liver failure 63 NOLVADEX 63 SGPT 63 tumor necrosis 63 Tamibarotene 63 bioavailable testosterone 63 topically administered 63 porcine derived 63 Acute Bacterial Sinusitis ABS 63 Cytarabine 63 lymphocytosis 63 venous thromboembolic events 63 forodesine 63 pioglitazone HCl 63 intravenous cyclophosphamide 63 Sudhir Agrawal D.Phil 63 sensory neuropathy 63 locoregional 63 evaluating tivozanib 63 echinocandin 63 EFFEXOR XR 63 ritonavir boosted protease inhibitor 63 Intravenous immunoglobulin 63 post thrombotic syndrome 63 bladder carcinoma 63 Helicobacter pylori eradication 63 NSAID induced 63 non hodgkin lymphoma 63 vinorelbine 63 systemic RNAi therapeutic 63 hyperprolactinemia 63 verteporfin 63 hepatic insufficiency 63 hepatocellular carcinoma HCC 63 PEGylated Fab fragment 63 allogeneic transplantation 63 Gorlin syndrome 63 Letairis ambrisentan 63 Cimzia TM 63 microtubule inhibitor 63 Nonspecific 63 Acute Radiation Syndrome ARS 63 neoplasia 63 FOLPI 63 HES CEL 63 Idiopathic Pulmonary Fibrosis 63 Azedra 63 autoantibody levels 63 Clinically significant 63 investigational monoclonal antibody 63 treat benign prostatic 63 IMiDs ® compound 63 IL 1ß 63 recombinant tissue plasminogen 63 BENICAR HCT 63 angiotensin converting enzyme inhibitors 63 Azathioprine 63 primary immunodeficiency PI 63 systemic antifungal 63 intestinal polyps 63 injected subcutaneously 63 beclomethasone dipropionate 63 post transplant lymphoproliferative 63 targeted radiotherapeutic 63 grade squamous intraepithelial 63 K ras mutations 63 recurrent glioblastoma multiforme GBM 63 tyrosine kinase inhibitor TKI 63 renal allograft 63 FOLFOX4 63 relapsed acute myelogenous 63 ISTODAX 63 chloride secretion 63 IFN beta 63 small lymphocytic lymphoma 63 angiotensin receptor blockers ARB 63 Systemic lupus erythematosus SLE 63 monoamine oxidase inhibitors 63 Chronic lymphocytic leukemia CLL 63 VELCADE melphalan 63 neutropenic sepsis 63 GP IIb IIIa inhibitors 63 ACTEMRA TM 63 polyp recurrence 63 Severe Sepsis 63 temsirolimus Torisel ® 63 essential thrombocythemia 63 antineoplastic 63 receiving XGEVA 63 gefitinib Iressa 63 mucositis 63 oblimersen 62 Lamotrigine 62 T Cell Lymphoma 62 Eisenmenger syndrome 62 antithrombotic therapy 62 adenomatous polyps 62 Epirubicin 62 amoxicillin clavulanate 62 haloperidol Haldol 62 gonadotropin releasing hormone GnRH 62 Enzyme Replacement Therapy 62 T1DM 62 R Saizen R 62 vasospasm 62 severe exacerbations 62 Zileuton 62 vincristine doxorubicin 62 intracranial hemorrhage ICH 62 hypertrophic scars 62 systemic lupus erythematosus psoriasis 62 Exacerbation 62 Interferon beta 62 cardiotoxic 62 Vaprisol 62 biliary strictures 62 octreotide acetate 62 Octreolin 62 Diabetic Macular Edema DME 62 colorectal neoplasms 62 metastatic uveal melanoma 62 Advanced Renal Cell 62 daily subcutaneous injections 62 dose melphalan 62 carcinoma HCC 62 thyroiditis 62 pretreatment serum 62 Platinol ® cisplatin 62 psoriatic arthritis PsA 62 AMEVIVE 62 induced anemia 62 LEP ETU 62 leukemia CML 62 decompensated liver disease 62 budesonide foam 62 atypical Hemolytic Uremic Syndrome 62 Relapsing Remitting Multiple Sclerosis 62 tamoxifen Nolvadex ® 62 immunotherapeutic agent 62 Azacitidine 62 immunodeficiency disorders 62 fluvastatin 62 renal scarring 62 bronchial hyperresponsiveness 62 relapsed ALL 62 pulmonary dysfunction 62 inhaled liposomal ciprofloxacin 62 omega interferon 62 Eltrombopag 62 immunomodulatory agents 62 serum phosphate 62 cytogenetic response 62 Tumor Necrosis Factor 62 piperacillin tazobactam 62 postoperative ileus 62 etoposide 62 antithrombotic agent 62 malignant lymphomas 62 gastrointestinal GI motility disorders 62 renal pelvis 62 cis retinoic acid 62 endoscopic resection 62 resectable pancreatic cancer